Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease
Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease have?
Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease has 74 citations in the OpenAlex counts ScholarIQ stores.
When was Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease published?
Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease has 2007 year in the ScholarIQ index.
What is the open-access status of Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease?
Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease has closed oa status in the ScholarIQ index.
What is the DOI of Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease?
The DOI for Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease is on the source record.
What is the PMID of Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease?
The PMID for Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease is on the source record.
What is the OpenAlex record for Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease?
The OpenAlex for Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease is on the source record.